Literature DB >> 8156101

Stimulation of endothelin-1 production by thrombin, but lack of interference by high ambient glucose in vitro.

S Baumgartner-Parzer1, O Wagner, P Nowotny, H Vierhapper, W Waldhäusl.   

Abstract

Diabetic vascular disease is associated with a state of hypercoagulability and altered endothelial properties, leading to elevated plasma levels of endothelium-derived peptides and proteins, e.g. endothelin-1, von Willebrand factor or fibronectin. This study determined dynamic immunoreactive endothelin-1 secretion by human umbilical vein endothelial cells exposed to thrombin (5 x 10(6) mU/l) in the presence (40 mmol/l) and absence (5.5 mmol/l) of excessive glucose in the cell culture medium. Exposure to high glucose and thrombin concentrations was initiated after cell confluency and applied for 24 h for measurements of endothelin-1 and for 2 and 5 h for the determination of preproendothelin-1, von Willebrand factor and fibronectin messenger ribonucleic acid. Comparisons were made versus cells incubated with normal glucose concentrations or with high mannose or NaCl concentrations as osmotic control. Neither preproendothelin-1, fibronectin and von Willebrand factor messenger ribonucleic acid expression nor endothelin-1 release was affected by high concentrations of glucose, mannose or sodium chloride.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156101     DOI: 10.1530/eje.0.1300271

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

1.  Levamisole induced apoptosis in cultured vascular endothelial cells.

Authors:  M Artwohl; T Hölzenbein; L Wagner; A Freudenthaler; W Waldhäusl; S M Baumgartner-Parzer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Modulation by high glucose of adhesion molecule expression in cultured endothelial cells.

Authors:  S M Baumgartner-Parzer; L Wagner; M Pettermann; A Gessl; W Waldhäusl
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.